ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "psoriatic arthritis and Disease Activity"

  • Abstract Number: 1149 • 2019 ACR/ARP Annual Meeting

    Are There Country Differences in Disease Activity and Life Impact of Psoriatic Arthritis? An Analysis of 436 Patients from 14 Countries

    Laure Gossec1, Juan Cañete 2, Ana-Maria Orbai 3, Ying-Ying Leung 4, Penelope Palominos 5, Rossana Scrivo 6, Andra Balanescu 7, Emmanuelle Dernis 8, Sandra Talli 9, Adeline Ruyssen-Witrand 10, Martin SOUBRIER 11, Sibel Zehra Aydin 12, Lihi Eder 13, Inna Gaydukova 14, Laura Coates 15, Umut Kalyoncu 16, Pascal Richette 17, M. Elaine Husni 18, Maarten de Wit 19, Josef Smolen 20, Ennio Lubrano 21 and Uta Kiltz 22, 1Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris, France, 2Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain, 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 4Department of Rheumatology and Immunology, Singapore General Hospital,, Singapore, Singapore, 5Serviço de Reumatologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul,, Porto Alegra, Brazil, 6Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza Università di Roma,, Rome, Italy, 7Sf Maria Hospital, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania, 8Rheumatology Department, Le Mans Central Hospital, Le Mans, France, 9Rheumatology Department, East-Tallinn Central Hospital, Tallinn, Estonia, 10Rheumatology Unit, Toulouse university Hospital, UMR 1027, Inserm, Université Paul Sabatier Toulouse III, Toulouse, France, 11CHU Gabriel Montpied, Clermont Ferrand, Auvergne, France, 12University of Ottawa Faculty of Medicine, Rheumatology,Ottawa Hospital Research Institute, 1967 Riverside Drive, Ottawa, ON, K1H 7W9, CANADA, Ottawa, Canada, 13Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada, 14North-western State medical university, St Petersburg, Russia, 15University of Oxford, Oxford, United Kingdom, 16Hacettepe University Department of Rheumatology, Ankara, Turkey, 17Department of Rheumatology, AP-HP Lariboisiere Hospital, Paris, France, 18Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 19Department of Medical Humanities, Amsterdam Public Health (APH), Amsterdam University Medical Centre, Amsterdam, Netherlands, 20Medical University of Vienna, Vienna, Austria, 2115. Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute ’Vincenzo Tiberio’, University of Molise, Campobasso, Italy, 22Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany

    Background/Purpose: In psoriatic arthritis (PsA), there is a substantial life impact perceived by patients, although many treatments are now available at least in countries with…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology